Patient Simulator Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Patient Simulator Market Size Analysis and Top Companies

The global patient simulator market size is estimated to hit around USD 1372.05 million by 2033, increasing from USD 574.28 million in 2023 with a CAGR of 8.98% from 2023 to 2033. The top companies operating in the patient simulator are Surgical Science Sweden AB, MEDICAL-X, Gaumard Scientific, Laerdal Medical, CAE Inc., Simulab Corporation, Kyoto Kagaku Co., Ltd., Limbs & Things LTD, Mentice AB, MedVision, and Others.

Market Report Coverage

Patient Simulator Key Players

• Surgical Science Sweden AB
• MEDICAL-X
• Gaumard Scientific
• Laerdal Medical
• CAE Inc.
• Simulab Corporation
• Kyoto Kagaku Co., Ltd.
• Limbs & Things LTD
• Mentice AB
• MedVision

Recent Developments

• January 2022: Gaumard Scientific Co. launched one of the first advanced multidisciplinary patient simulator, HAL® S5301. It feature life various functions such as movement to simulate symptoms of stroke and traumatic brain injury (TBI).

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344